Neonious Biotech

Neonious Biotech

Created using Figma
Neonious Biotech is introducing the Neonious Token (MDSIM) which is intended to
incentivize large numbers of people to form the Neonious Network, a group of
computers which will perform the molecular dynamics simulations, by distributing
newly generated MDSIMs among these people based on the computing power they
provide to the cause. With the molecular dynamics simulations, Neonious Biotech
will power Alzheimer and dementia research.
Pre-ICO
25 mai 2021
31 oct. 2021
100% terminé
Fonds levés - pas de données
objectif 250 000.00 USD
Casquette 30 000 000.00 USD
past
  • 1 MDSIM
    =
    0.1 USD
Détails du jeton
Téléscripteur
MDSIM
Offre totale
125000000
Distribution de jetons
80% Token Sale
11% Token Sale Marketing
6% Scientific Advisors
3% Neonious Employees
Devises Acceptées
ETH, USDC
Contribution min.
250000
USD
Détails de l'entreprise
Nom de l'entreprise enregistrée
Neonious Biotech
Pays enregistré
Germany
Bonus Structure
The price per token starts at 0.10 USD and will, as a minimum, increase by 0.01 USD after every 250,000 ordered tokens, making it worthwhile to buy early.
Détails supplémentaires
MVP / Prototype
Oui
Plate-forme
Ethereum
Pays restreints
Cuba, Iran, Lebanon, Libya, Syria, Sudan, Yemen
Les catégories
Plate-forme

Sur Neonious Biotech

We are pioneers of in silico prediction of drug safety and adverse reactions, limiting cost risks and reducing harm done to animals and humans.

To have the best tools for our drug analysis, we constantly optimize algorithms and pipelines and grow our distributed network which is a cost-efficient source for the needed computing power.

Our research is powered by the Neonious Network
and the Neonious Token (MDSIM).

Neonious is contracted to help to assess a drug for safety and adverse reactions.

Besides manual analysis, Neonious' research team utilizes computational pipelines

These pipelines queue simulations (docking + MD) to be run by the Neonious Network, paid with MDSIMs.

Sombody running the Neonious software, thus being part of the Neonious Network, runs the simulations.

This person is rewarded with easy transferable MDSIMs, which he or her can exchange for real money.

We believe it is beneficial to reduce risks by contract us to analyse your drug, preferable before starting preclinical research, latest before phase 2 of the human trials.

For lower cost, we can utilize the Neonious Network. Alternatively, the calculations can also be done on more private computing resources

Info technique

https://github.com/neonious/WelcomeToCodeRepository

% name% roadmap

  • 25/05/2021

  • Neonious Tokens can be ordered at the Neonious Biotech website. The earlier they are
    ordered, the cheaper the tokens are.
  • 01/07/2021

  • Extensively tested Neonious MD software available on GitHub (source code) and for
    download (Windows, macOS and Linux). May be used on testing network to generate new
    testing tokens.
  • 01/09/2021

  • Neonious MD software and mining contract passed security audit, results are published.
    Neonious Biotech starts the full ICO, preferably with a major exchange.
  • 31/10/2021

  • Neonious Token sale ends. Neonious Biotech will enable trading of Neonious Tokens for
    anyone on Uniswap by setting up an adequate liquidity pool.
  • Lire la suite
  • 01/11/2021

  • Neonious Biotech will start helping people set up their systems with the Neonious MD
    software to scale the Neonious Network.
  • 01/01/2022

  • Start of actual molecular dynamic simulations targeting dementia.
  • Early 2022

  • We plan to have reached an agreement for the Neonious Token to be listed at a major
    exchange.

Neonious Biotech Équipe

Vérifié 0%

Attention. Il y a un risque que les membres non vérifiés ne soient pas réellement membres de l'équipe

Thomas Rogg
Chief Executive Officer & Head of Development Team
non vérifié
Elena Elgina
Head of PR & Marketing
non vérifié
Maria Cristina Fadgy...
Head of Scientific Affairs
non vérifié
Martin Kämpf
Head of Digital Assets
non vérifié

Neonious Biotech Dernières nouvelles

  • En raison des différences temporelles dans les mises à jour des informations, des informations précises sur chaque projet ICO doivent être vérifiées sur son site web officiel ou via un autre canal de communication.
  • Cette information n'est pas une suggestion ou un conseil pour investir dans un financement ICO. Veuillez examiner vous-même les informations pertinentes et décider de la participation de l’OIC.
  • Si vous pensez que des problèmes ou des problèmes doivent être résolus concernant ce contenu, ou si vous souhaitez soumettre votre propre projet ICO pour figurer dans la liste, veuillez nous envoyer un courrier électronique.
Veuillez lire la clause de non-responsabilité et l'avertissement de risque. Afficher l'avertissement et l'avertissement de risque.